𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine

✍ Scribed by M. Gergov; J. N. Robson; E. Duchoslav; I. Ojanperä

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
242 KB
Volume
35
Category
Article
ISSN
1076-5174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liquid chromatography/electrospray ioniz
Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for β2-agonists in human or equine urine
✍ Mario Thevis; Georg Opfermann; Wilhelm Schänzer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

## Abstract Electrospray ionization (ESI) mass spectra of 19 common β~2~‐agonists were investigated in terms of fragmentation pattern and dissociation behavior of the analytes, proving the origin of fragment ions and indicating mechanisms of charge‐driven and charge‐remote fragmentation. Based on t

Liquid chromatographic/tandem mass spect
Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine
✍ Gary D. Byrd; Michael W. Ogden 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract A specific and rapid liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method was developed and validated for NNAL, a metabolite of the tobacco‐specific nitrosamine metabolite NNK. The metabolite was detected in smokers' urine with a limit of quantitation (LOQ) of 20 pg ml^−1^

Sensitive liquid chromatographic/tandem
Sensitive liquid chromatographic/tandem mass spectrometric method for the determination of beclomethasone dipropionate and its metabolites in equine plasma and urine
✍ Fuyu Guan; Cornelius Uboh; Lawrence Soma; Anne Hess; Yi Luo; Deborah S. Tsang 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

## Abstract Beclomethasone dipropionate (BDP) is a potent pro‐drug to beclomethasone (BOH) and is used in the treatment of chronic and acute respiratory disorders in the horse. The therapeutic dose of BDP (325 µg per horse) by inhalation results in very low plasma and urinary concentrations of BDP